Merck has dozens of collaborations out there with other companies drugs. The fact they are ony providing their drug(as far as we know) is not unusual at this phase. If the phase 2 shows really good results one might expect them to partner in a more meaningful way. Assuming it ever gets done.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links